Poster 15
Tapinarof Cream 1% Once Daily for the Treatment of Extensive Atopic Dermatitis in Adolescents and Children: Outcomes from the 4-Week...
top of page
DERM2023 POSTERS
We invite you to view the DERM2023 Posters. The posters are categorized by disease state.
Click on the disease state below to view all posters in that category.
Poster 16
Improvement Across Signs and Symptoms of Atopic Dermatitis with Lebrikizumab Use: Results from Two Phase 3, Randomized, Double-Blinded,...
27 views
Poster 17
Lebrikizumab Does Not Impact Vaccine-Induced Immune Responses: Results from A Phase 3 Study in Adult Patients with Moderate-to-Severe...
78 views
Poster 18
Assessing Imputation Methods with the Lebrikizumab Clinical Trial Program Authors: April W. Armstrong, Jonathan I. Silverberg, Jacob P....
33 views
Poster 19
Efficacy of Lebrikizumab in Patients with Atopic Dermatitis and Atopic Comorbidities: Pooled Results From 2 Phase 3 Monotherapy...
25 views
Poster 20
Patients with Moderate-to-Severe Atopic Dermatitis Experience Heterogeneous Disease Course Phenotypes: Results of a Real-World Study in...
29 views
Poster 21
Comparison of Two OTC Itch Relief Products After Single Application Authors: Christine Emesiani, PharmD; Matthew Meckfessel, PhD; Thu...
26 views
Poster 22
A Retrospective Multi-Center Case Series of Real-World Tralokinumab Use in Dupilumab-Experienced Patients Authors: Edward I. Herman, MD,...
22 views
Poster 23
Long-Term Safety and Efficacy of Tralokinumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: An interim analysis of ECZTEND...
18 views
Poster 24
Real-World Patient Characteristics and Early Patient-Reported Outcomes in Adult Patients with Moderate-to-Severe Atopic Dermatitis...
18 views
Poster 25
A Retrospective Case Series of Real-World Tralokinumab Use in Patients with Moderate-to-Severe Atopic Dermatitis Resistant to Systemic...
20 views
Poster 26
Long-Term Efficacy of Abrocitinib in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE EXTEND...
22 views
Poster 27
Clinically Important Benefits in Infants and Young Children with Moderate-to-Severe Atopic Dermatitis Not Achieving IGA 0/1 After 16...
28 views
Poster 28
Dupilumab Treatment in Patients with Hand and Foot Atopic Dermatitis: Results from a Phase 3, Randomized, Double-Blind,...
16 views
Poster 29
A Case Series of Live Attenuated Vaccine Administration in Dupilumab-Treated Children with Atopic Dermatitis Authors: Elaine C....
13 views
Poster 30
Long-Term Efficacy of Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis: Results from an Open-Label Extension Trial Up to 5...
15 views
Poster 31
Safety of Long-Term Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis: Results from an Open-Label Extension Trial...
18 views
Poster 32
Treatment-Emergent Adverse Events in Patients Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis Treated with Dupilumab...
19 views
Search by
Poster
Number
bottom of page